Pharmacoeconomics of Granulocyte Colony-Stimulating Factor: A Critical Review

被引：0
作者：
Gisoo Barnes
Ashutosh Pathak
Lee Schwartzberg
机构：
[1] Health Economics and Outcomes Research,
[2] Teva Pharmaceuticals,undefined
[3] Medical Affairs,undefined
[4] Teva Pharmaceuticals,undefined
[5] University of Tennessee Health Science Center,undefined
来源：
Advances in Therapy | 2014年 / 31卷
关键词：
Cost-effectiveness; Chemotherapy; Granulocyte colony-stimulating factor; Neutropenia; Oncology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：683 / 695
页数：12
相关论文
共 50 条
[41]   Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants [J].
Ahmad, A ;
Laborada, G ;
Bussel, J ;
Nesin, MJ .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (11) :1061-1065
[42]   Granulocyte and granulocyte macrophage colony-stimulating factors as therapy in human and veterinary medicine [J].
Fernandez-Varon, Emilio ;
Villamayor, Lucia .
VETERINARY JOURNAL, 2007, 174 (01) :33-41
[43]   Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy [J].
Wong, SF ;
Chan, HO .
PHARMACOTHERAPY, 2005, 25 (03) :372-378
[44]   Deletional mutation of the external domain of the human granulocyte colony-stimulating factor receptor in a patient with severe chronic neutropenia refractory to granulocyte colony-stimulating factor [J].
Sinha, S ;
Zhu, QS ;
Romero, G ;
Corey, SJ .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (10) :791-796
[45]   Paclitaxel, ifosfamide and cisplatin with granulocyte colony-stimulating factor or recombinant human interleukin 3 and granulocyte colony-stimulating factor in ovarian cancer: A feasibility study [J].
Veldhuis, GJ ;
Willemse, PHB ;
Beijnen, JH ;
Boonstra, H ;
Piersma, H ;
vanderGraaf, WTA ;
deVries, EGE .
BRITISH JOURNAL OF CANCER, 1997, 75 (05) :703-709
[46]   Aortitis Associated with Prophylactic Short-acting Granulocyte Colony-stimulating Factor Administration: A Case Report and Review of the Literature [J].
Masuda, Yasutaka ;
Oyama, Takashi ;
Nakazaki, Kumi ;
Nakai, Yudai ;
Sasaki, Ken ;
Matsuda, Kensuke ;
Masamoto, Yosuke ;
Kurokawa, Mineo .
INTERNAL MEDICINE, 2023, 62 (11) :1647-1652
[47]   Highly Expressed Granulocyte Colony-Stimulating Factor (G-CSF) and Granulocyte Colony-Stimulating Factor Receptor (G-CSFR) in Human Gastric Cancer Leads to Poor Survival [J].
Fan, Zhisong ;
Li, Yong ;
Zhao, Qun ;
Fan, Liqiao ;
Tan, Bibo ;
Zuo, Jing ;
Hua, Kelei ;
Ji, Qiang .
MEDICAL SCIENCE MONITOR, 2018, 24 :1701-1711
[48]   TiclopidineAgranulocytosis treated with granulocyte colony-stimulating factor: case report [J].
Reactions Weekly, 1998, 695 (1) :12-12
[49]   Serum Granulocyte Colony-Stimulating Factor and Alzheimer's Disease [J].
Barber, Robert C. ;
Edwards, Melissa I. ;
Xiao, Guanghua ;
Huebinger, Ryan M. ;
Diaz-Arrastia, Ramon ;
Wilhelmsen, Kirk C. ;
Hall, James R. ;
O'Bryant, Sid E. .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2012, 2 (01) :353-360
[50]   Endocrine effects of granulocyte colony-stimulating factor in cancer patients [J].
Rovelli, F ;
Barni, S ;
Tancini, G ;
Ardizzoia, A ;
Lissoni, P .
TUMORI, 1995, 81 (06) :438-439
12345